- Filed
- May 15, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 14, 2025 | 117.89M sh |
| Stock Issued | Q1 2025 · Mar 31, 2025 | 0 sh |
| Capex | Q1 2025 · Mar 31, 2025 | $0 |
| Capex | Q1 2025 · Mar 31, 2024 | $0 |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $2.41M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $2.41M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $2.41M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $2.41M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $3.08M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $3.3M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $3.09M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $3.31M |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 117.89M sh |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$127.94K |
| Stockholders Equity restated | Q1 2025 · Mar 31, 2024 | $1.87M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $1.82M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $0.00 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $5.97K |
| Net Income | Q1 2025 · Mar 31, 2024 | −$322.68K |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$237.49K |
| Revenue | Q1 2025 · Mar 31, 2024 | $0 |